Substance / Medication

Riboflavin mononucleotide

Overview

Active Ingredient
riboflavin 5'-phosphate
RxNorm CUI
1925821
Labeler: V2 Pharma LLCUpdated: 2025-05-16T00:00:00.000ZFull label on DailyMed

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Detailed dosage and administration information is available in the full FDA drug label.

View full prescribing information on DailyMed

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Research Evidence

Published studies and systematic reviews

Sort:
Effects of deficiency or supplementation of riboflavin on energy metabolism: a systematic review with preclinical studies.
da Silva-Araújo Eulália Rebeca, Toscano Ana Elisa, Silva Paula Brielle Pontes et al. · Nutr Rev · 2025
PMID: 38719205Meta-Analysis
Correcting a marginal riboflavin deficiency improves hematologic status in young women in the United Kingdom (RIBOFEM).
Powers Hilary J, Hill Marilyn H, Mushtaq Sohail et al. · Am J Clin Nutr · 2011
PMID: 21525198RCT
Riboflavin status in acute ischaemic stroke.
Gariballa S, Ullegaddi R · Eur J Clin Nutr · 2007
PMID: 17299470RCT
Riboflavin Deficiency and Apoptosis: A Review.
Zhang Bo, Hou Shuisheng, Tang Jing · J Nutr · 2025
PMID: 39510506Review

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Adverse reaction and safety data for this drug is sourced from the FDA-approved label.

View adverse reactions & drug interactions on DailyMed

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Riboflavin mononucleotide (substance)
SNOMED CT
53499005
UMLS CUI
C0016388
RxNorm CUI
1925821
Labeler
V2 Pharma LLC

Clinical Data

This intervention maps to 1 entities in the Healos knowledge graph.

1
Conditions
0
Biomarkers
0
Specialists
0
Symptoms

Data is sourced from SNOMED CT, UMLS, and the Healos clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.